The neutrophil respiratory burst and tissue injury in septic acute lung injury: the effect of cyclooxygenase inhibition in swine.
Cyclooxygenase inhibition has been proposed as treatment for sepsis-induced acute lung injury. However, the mechanism of protection offered by the cyclooxygenase inhibitor ibuprofen is not well understood. To elucidate this mechanism, the effects of ibuprofen on the neutrophil respiratory burst and alveolar-capillary membrane leak were studied. Anesthetized swine (15 to 25 kg) were intubated and mechanically ventilated (fraction of inspired oxygen, 0.5). Control animals (n = 5) received a sham infusion of 0.9% NaCl, animals with sepsis (n = 10) received a 1-hour infusion of live Pseudomonas aeruginosa (5 x 10(8) colony-forming units/ml at 0.3 ml/20 kg/hr), and treated animals (ibuprofen-treated control animals [n = 4] or ibuprofen-treated animals with sepsis [n = 9]) received ibuprofen (12.5 mg/kg at 0 and 120 minutes). All animals were studied for 300 minutes. Neutrophils were isolated at 0, 60, and 300 minutes. Neutrophil superoxide anion production (O2-) was assessed in a kinetic fashion (in nanomoles per minute) by superoxide dismutase-inhibitable cytochrome C reduction (phorbol myristate acetate stimulation). Bronchoalveolar lavage protein estimation (0 and 300 minutes) and extravascular lung water (double indicator dilution) were performed to assess alveolar-capillary membrane leak. Ibuprofen significantly attenuated sepsis-enhanced maximum neutrophil generation of O2- (6.0 +/- 0.5 nmol/min for animals with sepsis, 300 minutes, vs 4.1 +/- 0.5 nmol/min for ibuprofen-treated animals, with sepsis, 300 minutes; p less than 0.05), indicating an in vivo down-regulatory effect on neutrophil oxidant generation. Ibuprofen also prevented increased airspace bronchoalveolar lavage protein and extravascular lung water accumulation, suggesting a protective effect on the alveolar-capillary membrane. This protective effect of ibuprofen in acute lung injury may be through a decreased neutrophil respiratory burst.
Carey
P D
PD
Department of Surgery, Medical College of Virginia, Richmond 23229.
Jenkins
J K
JK
Byrne
K
K
Walsh
C J
CJ
Fowler
A A
AA
Sugerman
H J
HJ
D000208:Acute Disease; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D002196:Capillaries / Q000187:drug effects / Q000503:physiopathology; D007052:Ibuprofen / Q000494:pharmacology*; D007700:Kinetics; D007958:Leukocyte Count / Q000187:drug effects; D008168:Lung / Q000098:blood supply / Q000187:drug effects / Q000503:physiopathology*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000503:physiopathology; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D011506:Proteins / Q000032:analysis; D011552:Pseudomonas Infections / Q000097:blood / Q000503:physiopathology*; D011650:Pulmonary Alveoli / Q000098:blood supply; D011652:Pulmonary Circulation / Q000187:drug effects; D018805:Sepsis / Q000097:blood / Q000503:physiopathology*; D013481:Superoxides / Q000097:blood*; D013552:Swine; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D011506:Proteins; D013481:Superoxides; D013755:Tetradecanoylphorbol Acetate; D007052:Ibuprofen